DNTH

Dianthus Therapeutics Inc. (DNTH)

US
$ 29.06-2.81%

Price Chart

Key Statistics

Market Cap
$ 586.92M
P/E Ratio
0.00
Revenue (TTM)
$ 6.52M
Volume
168.3K
52W High
$ 32.27
52W Low
$ 13.37
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
18.9108
200-Day MA
22.3364
52 Week High
32.27
52 Week Low
13.365

About DNTH

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases.

Employees
78
Headquarters
New York, NY
CEO
Mr. Marino Garcia M.B.A.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96